UCLA's Jonsson Comprehensive Cancer Center
UCLA's Jonsson Comprehensive Cancer Center
UCLA
If you have been diagnosed with cancer, call the:
UCLA Cancer Hotline
(888) ONC-UCLA [ (888) 662-8252 ]
9am-5pm Pacific time, Monday through Friday
If you have been diagnosed with cancer and are interested in clinical trials, call the:
Clinical Trials Hotline
(888) 798-0719
9am-5pm Pacific time, Monday through Friday
If you would like a cancer screening or general health care, call the:
UCLA Health System
(800) UCLA-MD1 [ (800) 825-2631 ]
9am-5pm Pacific time, Monday through Friday
You can also email access@mednet.ucla.edu with general questions.
UCLA's Jonsson Comprehensive Cancer Center
8-684 Factor Building
Box 951781
Los Angeles, CA 90095-1781
Phone: (310) 825-5268
Fax: (310) 206-5553
E-mail: jcccinfo@mednet.ucla.edu
Use the above information to contact JCCC's administrative offices. You will not be able to make an appointment or access other patient services through these offices. To do so, visit our Cancer Hotlines.
Jonsson Cancer Center Foundation at UCLA
8-950 Factor Building
Box 951780
Los Angeles, CA 90095-1780
Phone: (310) 206-0675
Fax: (310) 206-5553
E-mail: jccfinfo@mednet.ucla.edu
For website-related questions or comments, e-mail jcccwebmaster@cancer.mednet.ucla.edu or call (310) 206-4430.
UCLA's Jonsson Comprehensive Cancer Center is internationally renowned for innovative cancer research and the best in cancer diagnosis, treatment and prevention in Los Angeles and Southern California.]
History
In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care.
In 1976, the cancer center at UCLA was designated "comprehensive" by the National Cancer Institute (NCI). Of the 63 NCI cancer center programs nationwide, only 41 receive the gold-star comprehensive status. UCLA's Jonsson Comprehensive Cancer Center (JCCC) receives this honor for maintaining the highest standards of excellence in patient care, education, basic science, clinical research and cancer prevention.
JCCC Today
JCCC has established an international reputation in a number of areas, such as:
Developing new cancer therapies
Providing the best in experimental and traditional treatments
Expertly guiding and training the next generation of medical researchers
Numerous successful targeted therapies were developed based on basic science done in UCLA laboratories and later clinical research with UCLA patients. A few of the more well-known therapies include:
Herceptin, a targeted breast cancer drug and the first approved treatment that attacks cancer at its genetic roots
Gleevec, a once-a-day pill that targets a common form of adult leukemia called chronic myelogenous leukemia, or CML
Sprycel, also a pill that targets CML
Tarceva, a targeted lung cancer drug
Avastin, a targeted drug for colorectal cancer, lung cancer and breast cancer
These treatments are just the most well-known of our JCCC firsts.
With a membership of more than 350 physicians and scientists, JCCC is one of the largest comprehensive cancer centers in the nation. We handle more than 20,000 patient visits per year and conduct hundreds of clinical trials, providing the latest in experimental cancer treatments. Our depth lets us offer a wide array of benefits to patients.
For more information, please contact us at jcccinfo@mednet.ucla.edu.
For Patients, Potential Patients and Referring Physicians
© 2009 UCLA Jonsson Comprehensive Cancer Center. All Rights Reserved.
Votes:13